Combined host-derived and microbiological biomarkers
By Marion Arce, Cristina Lima, Leire Virto, Juan Daniel Gamonal, Diogo Banaco, Mario Romandini, Mariano Sanz
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Implant clinics may improve early detection of peri-implant bone loss by combining IL-1β testing with bleeding-on-probing or probing-depth checks rather than relying on any single marker.
Key points
- University cohort study followed subjects with dental implants for a mean 3.9 years and defined bone loss as > 1 mm radiographic change.
- Increased IL-1β, T. denticola, Fusobacterium spp., and T. forsythia each correlated with bone loss in unadjusted analysis.
- After adjustment for clinical parameters, no single biomarker retained statistical significance.
- IL-1β plus bleeding-on-probing or probing depth reached AUC 0.97, outperforming individual clinical measures but not the full clinical-parameter set.
Who should care
Read the original on Clinical Oral Implants Research
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Dentists Win at the Supreme Court, But Conduent Gets Tossed a Bone
- ·Regulatory
FDA recalls 4 million tubes of fluoride toothpaste
- ·Research
Premature occlusal contacts induce MRONJ in osseointegrated dental implants
- ·Regulatory
Dental sleep group pens letter to FDA over consumer protections for oral appliances